Transmedics Group Inc (TMDX) Moves 3.76% Higher: These Numbers are Too Good to be True

Transmedics Group Inc (NASDAQ: TMDX) started the day on Wednesday, with a price increase of 3.76% at $75.35, before settling in for the price of $72.62 at the close. Taking a more long-term approach, TMDX posted a 52-week range of $36.42-$99.63.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The Healthcare sector firm’s twelve-monthly sales growth has been 95.07% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 8.36%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 95.31%. This publicly-traded company’s shares outstanding now amounts to $32.67 million, simultaneously with a float of $31.48 million. The organization now has a market capitalization sitting at $2.47 billion. At the time of writing, stock’s 50-day Moving Average stood at $82.54, while the 200-day Moving Average is $72.01.

Transmedics Group Inc (TMDX) Ownership Facts and Figures

Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Devices Industry. Transmedics Group Inc’s current insider ownership accounts for 3.79%, in contrast to 109.01% institutional ownership. According to the most recent insider trade that took place on Apr 01 ’24, this organization’s Chief Financial Officer sold 15,000 shares at the rate of 74.01, making the entire transaction reach 1,110,150 in total value, affecting insider ownership by 23,299. Preceding that transaction, on Mar 08 ’24, Company’s Chief Financial Officer sold 1,903 for 87.63, making the whole transaction’s value amount to 166,760. This particular insider is now the holder of 23,299 in total.

Transmedics Group Inc (TMDX) Earnings and Revenue Records

In the latest quarterly report released, which was put into the public domain on 12/30/2023, the organization reported $0.12 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.03) by $0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.

Transmedics Group Inc’s EPS increase for this current 12-month fiscal period is 95.31% and is forecasted to reach 0.57 in the upcoming year.

Transmedics Group Inc (NASDAQ: TMDX) Trading Performance Indicators

Let’s observe the current performance indicators for Transmedics Group Inc (TMDX). It’s Quick Ratio in the last reported quarter now stands at 8.49. The Stock has managed to achieve an average true range (ATR) of 4.33. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 10.20.

In the same vein, TMDX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.77, a figure that is expected to reach -0.02 in the next quarter, and analysts are predicting that it will be 0.57 at the market close of one year from today.

Technical Analysis of Transmedics Group Inc (TMDX)

If we take a close look at the recent performances of Transmedics Group Inc (NASDAQ: TMDX), its last 5-days Average volume was 0.73 million that shows progress from its year to date volume of 0.64 million. During the previous 9 days, stock’s Stochastic %D was recorded 43.54% While, its Average True Range was 4.32.

Raw Stochastic average of Transmedics Group Inc (TMDX) in the period of the previous 100 days is set at 53.72%, which indicates a major rise in contrast to 45.50% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 40.91% that was lower than 50.90% volatility it exhibited in the past 100-days period.